News

August 13, 2019 - ViSi Mobile Detects Many Types of Patient Deterioration Read More

August 12, 2019 - Asteres ScriptCenter Products now on ECAT Read More

August 7, 2019 - Glycomine, Inc. Announces $33 Million Series B Financing to Advance its Therapy for a Congenital Disease of Glycosylation Read More

August 6, 2019 - Learn about ViSi Mobile 1.5G and see it in action! Read More

July 24, 2019 - ViaCyte to Expand Board of Directors with Two New Appointments Read More

July 23, 2019 - Continuous Surveillance Monitoring: the Standard of Care Read More

July 9, 2019 - Vital Signs Workflow — The ViSi difference Read More

July 2, 2019 - ViSi Mobile SpO2 vs. Traditional SpO2 Read More

June 27, 2019 - ViaCyte Appoints Sandra E. Poole to Board of Directors Read More

June 17, 2019 - Detect the Undetectead Read More